MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Single-photon emission computed tomography(SPECT)"

  • 2024 International Congress

    Dopamine transporter imaging to predict the risk of aspiration in patients with Parkinson’s disease

    J. Tanimura, T. Yamamoto, Y. Shigemoto, N. Sato, Y. Takahashi (Kodaira, Tokyo, Japan)

    Objective: To assess the predictive performance of clinical measures, including dopamine transporter (DaT) imaging, for identifying aspiration risk in patients with Parkinson’s disease (PD). Background:…
  • 2024 International Congress

    Improved Quantification of DAT-SPECT significantly increases its Performance as an Imaging Biomarker in Parkinson’s Disease

    R. Gunn, Z. Fan, D. Russell, J. Eberling, K. Marek, J. Seibyl, FOR. Ppmi (London, United Kingdom)

    Objective: To investigate potential improvements in signal-to-noise (SNR) derived from advanced image analysis of longitudinal DAT-SPECT data. Background: [123I]Ioflupane SPECT (DAT-SPECT) has been widely used…
  • 2024 International Congress

    Dopaminergic denervation and focal motor progression in early Parkinson’s Disease: A 5-year longitudinal study

    MA. Ruiz Yanzi, M. Matarazzo, JA. Pineda-Pardo, T. Jiménez-Castellanos, MHG. Monje, A. Sánchez-Ferro, R. Martínez-Fernández, C. Gasca-Salas, JA. Obeso (Madrid, Spain)

    Objective: To evaluate the progression of posterior putamen dopaminergic denervation in relation to motor progression in the less affected and more affected side of the…
  • 2024 International Congress

    Predictive Accuracy of Baseline DaT-SPECT for Freezing of Gait at 5, 7, and 10-year Follow up in The PPMI Cohort

    J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

    Objective: To see if segmentation models of baseline DaT-SPECT striatal binding ratios (SBR) will predict freezing of gait (FoG) in Parkinson’s Disease over a 5,…
  • 2023 International Congress

    Network attack tolerance: A resilience proxy for Parkinson’s disease?

    A. Asendorf, A. Temizyürek, M. Banwinkler, V. Dzialas, THE. Parkinson-Progression-Marker-Initiative, T. van Eimeren, M. Hoenig (Cologne, Germany)

    Objective: To investigate if individual capacity in network attack tolerance moderates the relationship between striatal dopamine loss and symptom severity in PD. Background: It was…
  • 2023 International Congress

    Diabetes impact on nigrostriatal vulnerability in Parkinson’s Disease

    A. Galli, A. Pilotto, C. Zatti, C. Tirloni, A. Lupini, B. Paghera, A. Padovani (Brescia, Italy)

    Objective: aim of the study was to investigate whether diabetes mellitus influences nigrostriatal dopaminergic vulnerability in drug-naïve patients with early-stage Parkinson’s Disease (PD). Background: recently,…
  • 2023 International Congress

    A 20-Year Follow-Up Case Report with Three DaT-SPECT Scans in Parkinson’s Disease Diagnosis

    S. Virameteekul, K. Bhatia (London, United Kingdom)

    Objective: To describe a patient who underwent multiple DAT-SPECT scans over a 20-year clinical follow-up period in three distinct clinical settings: a normal scan excluding…
  • 2023 International Congress

    Rest Tremor in Parkinson’s Disease Is Associated with Increased Ipsilateral DAT Binding

    K. Niemi, J. Sunikka, V. Kaasinen, J. Joutsa (Turku, Finland)

    Objective: To investigate the connection between striatal dopamine transporter binding and cardinal motor symptoms of Parkinson’s disease. Background: The three cardinal motor symptoms of Parkinson’s…
  • 2023 International Congress

    Increased free water in the putamen in idiopathic REM sleep behaviour disorder

    D. Zhang, L. Zhou, J. Liu, T. Wu (Beijing, China)

    Objective: This study aimed to evaluate the free water in the dorsoposterior putamen of idiopathic REM sleep behaviour disorder (iRBD) patients, which is considered a…
  • 2023 International Congress

    Hemiparkinsonism secondary to a cerebral cavernous malformation (CCM)

    M. González Sánchez, B. De-La-Casa Fages, JR. Pérez Sánchez, A. Contreras Chicote, S. Secades García, E. Luque Buzo, Y. Fernández Bullido, G. Lafuente Gómez, O. Mateo Sierra, FJ. Grandas Pérez (Madrid, Spain)

    Objective: To describe a case of secondary parkinsonism of unhabitual cause and complex treatment. Background: Secondary parkinsonism constitutes approximately 15% of all parkinsonism cases in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 16
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley